6-Benzylamino-7-deazapurine

CAS: 60972-04-5

Ref. 3D-FB04580

Informação sobre produto

• Nome: 6-Benzylamino-7-deazapurine
• Sinónimos: 4-Benzylamino-1H-pyrrole[2,3-d]pyrimidine
• Marca: Biosynth
• Descrição: 6-Benzylamino-7-deazapurine is a drug that has been shown to be effective in the treatment of pancreatic cancer. It is a monomer that reacts with nucleophiles such as 6-mercaptopurine, which are present in the human lung. The reaction generates an exergonic molecule that can be used to generate ATP and regenerate NAD+ during irradiation. This process has been observed using kinetic studies on human colon adenocarcinoma cells. 6-Benzylamino-7-deazapurine can also react with triazole compounds to form a linker and increase the rate of polymerization. The optimization of this reaction time could lead to more efficient cancer treatments.

Propriedades químicas

• Peso molecular: 224.26 g/mol
• Fórmula: C₁₃H₁₂N₄
• Pureza: Min. 95%
• Cor/forma: Powder
• InChI: InChI=1S/C13H12N4/c1-2-4-10(5-3-1)8-15-13-11-6-7-14-12(11)16-9-17-13/h1-7,9H,8H2,(H2,14,15,16,17)
• Chave InChI: InChIKey=XQTDTJWTCBSTMC-UHFFFAOYSA-N
• SMILES: c1ccc(CNc2ncnc3[nH]ccc23)cc1